T1	Participants 208 222	COPD patients.
T2	Participants 1083 1089	study.
T3	Participants 1090 1183	Participants can use any background treatment for COPD except inhaled anticholinergic agents.
T4	Participants 1184 1241	The study encompasses a wide range of COPD patients, e.g.
T5	Participants 1242 1317	patients with stable cardiac diseases including arrhythmia can be included.
T6	Participants 1318 1403	Clinical sites are international and include both primary care as well as specialists
T7	Participants 1405 1504	RESULTS To date, over 17,000 participants have been randomized from over 1200 sites in 50 countries
